Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Immunodeficiency-18 is an autosomal recessive primary immunodeficiency characterized by onset in infancy or early childhood of recurrent infections. Immunologic work-up of the IMD18 SCID patients shows a T cell-negative, B cell-positive, natural killer (NK) cell-positive phenotype, whereas T-cell development is not impaired in the mild form of IMD18.
Features include always present findings: Decreased CD3+ T cell proportion, Decreased circulating total IgA, Abnormal T cell proliferation, and Decreased CD4+ T cell proportion and others; and common findings: Decreased circulating total IgM. 15 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Lungs and breathing | 2 | Recurrent pneumonia, Recurrent respiratory infections |
CD3E encodes CD3 epsilon subunit of T-cell receptor complex (207 aa). Part of the TCR-CD3 complex present on T-lymphocyte cell surface that plays an essential role in adaptive immune response. Highest expression in Whole Blood (103.4 TPM) and Spleen (94.8 TPM).
Immunodeficiency 18 is caused by mutations in the CD3E gene on chromosome 11.
CD3E is classified as a druggable target (Druggable Genome, External Side Of Plasma Membrane, and Kinase categories) with score 1.5.
Genetic testing for CD3E is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for immunodeficiency 18 has been reported in the published literature.
Phenotype severity distribution: 9 always present features, 1 common feature.
No clinical trials have been registered for immunodeficiency 18.
209 publications have been identified in PubMed for immunodeficiency 18. Kisho has analyzed 116 by research type. Research spans Epidemiology / Natural History (30%), Review / Meta-Analysis (22%), and Basic Science / Preclinical (17%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 35 | 30% |
Data assembled from 6 of 12 sources · Last updated Sep 18, 2026, 7:12 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Blood and immune system |
2 |
Recurrent respiratory infections, Immunodeficiency |
Digestive system | 1 | Recurrent gastroenteritis |
Ears | 1 | Recurrent otitis media |
Research summaries
26 |
22% |
Laboratory research | 20 | 17% |
Clinical study results | 13 | 11% |
Patient case studies | 10 | 9% |
Testing and diagnosis research | 8 | 7% |
New treatment approaches | 3 | 3% |
Other research | 1 | 1% |
Okumura N (2026). [PMID: 39982831](https://pubmed.ncbi.nlm.nih.gov/39982831/). *Clin Infect Dis*. [Clinical Trial Publication]
Nzivo M (2026). [PMID: 41902297](https://pubmed.ncbi.nlm.nih.gov/41902297/). *Viruses*. [Review / Meta-Analysis]
Obi P (2026). [PMID: 41826685](https://pubmed.ncbi.nlm.nih.gov/41826685/). *Nat Microbiol*. [Basic Science / Preclinical]
Kekeç H (2026). [PMID: 41452243](https://pubmed.ncbi.nlm.nih.gov/41452243/). *Balkan Med J*. [Epidemiology / Natural History]
Jang Y (2026). [PMID: 42011001](https://pubmed.ncbi.nlm.nih.gov/42011001/). *J Korean Med Sci*. [Epidemiology / Natural History]
Yue J (2026). [PMID: 41147740](https://pubmed.ncbi.nlm.nih.gov/41147740/). *Arthritis Rheumatol*. [Diagnostic / Biomarker]
Veenstra TD (2026). [PMID: 42129076](https://pubmed.ncbi.nlm.nih.gov/42129076/). *Adv Exp Med Biol*. [Review / Meta-Analysis]
Konopnicki D (2026). [PMID: 40356381](https://pubmed.ncbi.nlm.nih.gov/40356381/). *Clin Infect Dis*. [Clinical Trial Publication]
Mpofu-Dobo L (2026). [PMID: 42198726](https://pubmed.ncbi.nlm.nih.gov/42198726/). *Viruses*. [Review / Meta-Analysis]
Kaila A (2026). [PMID: 41693509](https://pubmed.ncbi.nlm.nih.gov/41693509/). *Epidemiol Infect*. [Epidemiology / Natural History]